Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alison Dawn Laws, M.D.

Concepts (78)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms162021188621.440 Why?
Mastectomy, Segmental420209281.210 Why?
Neoadjuvant Therapy5202121881.100 Why?
Carcinoma, Ductal, Breast4201911031.090 Why?
Ultrasonography, Mammary320192570.990 Why?
Carcinoma, Lobular320194650.850 Why?
Diagnostic Services12019400.830 Why?
Mastectomy5202016340.830 Why?
Health Plan Implementation220193620.760 Why?
Sentinel Lymph Node Biopsy320206610.760 Why?
Mammography5202024300.700 Why?
Neoplasm, Residual220198790.700 Why?
Lymphatic Metastasis2202130310.600 Why?
Waiting Lists120196450.580 Why?
Carcinoma, Intraductal, Noninfiltrating120208800.510 Why?
Carcinoma in Situ120188050.500 Why?
Early Detection of Cancer3202024740.470 Why?
Reoperation2201941260.470 Why?
Genetic Testing1202130880.360 Why?
Biopsy1202067000.350 Why?
Venous Thromboembolism1201812880.350 Why?
Guideline Adherence1201823430.340 Why?
Intraoperative Period220185620.320 Why?
Lymph Node Excision3202011620.300 Why?
Models, Statistical1201851060.260 Why?
Antineoplastic Combined Chemotherapy Protocols32021106290.240 Why?
Axilla220205140.230 Why?
Prognosis72021280300.220 Why?
Practice Guidelines as Topic1201874880.210 Why?
Risk Assessment22020229300.210 Why?
Genetic Predisposition to Disease12021165120.190 Why?
Canada2202018450.180 Why?
Antineoplastic Agents12021136730.170 Why?
Chemotherapy, Adjuvant3202133850.170 Why?
Frozen Sections120161690.160 Why?
Neoplasm Recurrence, Local5202181600.150 Why?
Critical Pathways120194320.150 Why?
Ambulatory Surgical Procedures120193840.150 Why?
Rural Health Services120183590.140 Why?
Receptors, Estrogen5202120870.140 Why?
Female1520213653910.140 Why?
Neoplasm Invasiveness2201937560.130 Why?
Aged, 80 and over52019577070.130 Why?
Magnetic Resonance Imaging12020321080.130 Why?
Middle Aged1020212108020.120 Why?
Lymph Nodes2202033370.120 Why?
Neoplasm Staging32021110470.110 Why?
Follow-Up Studies52019388860.110 Why?
Humans1620216613870.110 Why?
Perioperative Care1201910520.110 Why?
Radiotherapy1201816780.110 Why?
Retrospective Studies52021632600.110 Why?
Receptors, Progesterone3202011020.100 Why?
Receptor, erbB-24202122310.100 Why?
Combined Modality Therapy2201990370.100 Why?
Adult720212063720.100 Why?
Aged720191569980.090 Why?
Survival Rate22019132540.080 Why?
Massachusetts1202087170.080 Why?
Hemorrhage1201830290.080 Why?
Prospective Studies22021469540.080 Why?
Reconstructive Surgical Procedures1201819970.080 Why?
Predictive Value of Tests12021150440.070 Why?
Quality Improvement1201934740.070 Why?
Multivariate Analysis12018127250.070 Why?
Health Services Accessibility1201847720.050 Why?
Age Factors12018190610.050 Why?
Postoperative Complications22019147650.050 Why?
Young Adult32019541130.040 Why?
Time Factors12019418810.040 Why?
Geography120186850.040 Why?
Risk Factors12018669060.030 Why?
Disease-Free Survival1202170810.030 Why?
Risk1202098290.020 Why?
Patient Discharge1201925810.020 Why?
Gene Expression Profiling1202094530.020 Why?
Treatment Outcome12019591730.010 Why?
Adolescent12019828510.010 Why?
Laws's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.